Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6226
Children's Place
PLCE
$53.4M
| $34.9K | ﹤0.01% |
10,382
-23,773
| -70% | -$96.4K |
|
|
CIRC
6227
Circle8 Group
CIRC
$71.1M
| $34.5K | ﹤0.01% |
11,384
-689
| -6% | -$2.17K |
|
|
ACTU
6228
Actuate Therapeutics
ACTU
$27.5M
| $34K | ﹤0.01% |
+12,408
| New | +$51.4K |
|
6229
Fathom Holdings
FTHM
$29.2M
| $32.6K | ﹤0.01% |
61,580
-9,560
| -13% | -$9.57K |
|
|
ANGX
6230
Angel Studios
ANGX
$806M
| $32.6K | ﹤0.01% |
+10,703
| New | +$41K |
|
6231
Key Tronic
KTCC
$41.3M
| $32K | ﹤0.01% |
11,739
-2,941
| -20% | -$8.37K |
|
6232
Werewolf Therapeutics
HOWL
$20.3M
| $31.9K | ﹤0.01% |
38,266
+4,193
| +12% | +$2.87K |
|
6233
Fractyl Health
GUTS
$126M
| $31.3K | ﹤0.01% |
68,433
-3,356,764
| -98% | -$3.09M |
|
|
DWTX
6234
Dogwood Therapeutics
DWTX
$50.4M
| $30.8K | ﹤0.01% |
+14,598
| New | +$43K |
|
|
STEX
6235
Streamex Corp
STEX
$75.4M
| $30.3K | ﹤0.01% |
26,852
-23,396
| -47% | -$59.5K |
|
|
NIPG
6236
NIP Group Inc
NIPG
$178M
| $29.1K | ﹤0.01% |
1,426
-77
| -5% | -$2.13K |
|
6237
Roadzen Inc Warrants
RDZNW
$8.64M
| $28.8K | ﹤0.01% |
239,874
| – | – |
|
|
YOOV
6238
DELISTED
Concorde International Group
YOOV
| $28.3K | ﹤0.01% |
15,882
| – | – |
|
|
FBGL
6239
FBS Global
FBGL
$7.16M
| $26.6K | ﹤0.01% |
+44,605
| New | +$37.2K |
|
6240
United Maritime
USEA
$24.4M
| $26.5K | ﹤0.01% |
13,140
-737
| -5% | -$1.41K |
|
|
SLSN
6241
Solesence Inc
SLSN
$69.4M
| $26.2K | ﹤0.01% |
27,624
+8,910
| +48% | +$11.3K |
|
|
DFDVW
6242
DeFi Development Corp Warrant
DFDVW
$1.25M
| $25.9K | ﹤0.01% |
47,054
-8,524
| -15% | -$9.46K |
|
|
HPAI
6243
Helport AI
HPAI
$16.4M
| $25.7K | ﹤0.01% |
+17,149
| New | +$51.3K |
|
6244
Odyssey Marine Exploration
OMEX
$40.9M
| $25.4K | ﹤0.01% |
+30,471
| New | +$51.8K |
|
6245
Educational Development Corp
EDUC
$12.4M
| $25.1K | ﹤0.01% |
+19,890
| New | +$27.3K |
|
6246
Cytosorbents Corp
CTSO
$23.9M
| $24.9K | ﹤0.01% |
43,947
+7,995
| +22% | +$5.46K |
|
|
ARAI
6247
Arrive AI Inc
ARAI
$15.5M
| $24.3K | ﹤0.01% |
+30,515
| New | +$48.5K |
|
6248
Envoy Medical
COCH
$51.7M
| $24.3K | ﹤0.01% |
+36,462
| New | +$24.9K |
|
6249
PodcastOne
PODC
$118M
| $23.8K | ﹤0.01% |
+11,661
| New | +$29.4K |
|
6250
Caesarstone
CSTE
$72.3M
| $23.4K | ﹤0.01% |
21,891
-6,087
| -22% | -$10K |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.